Krystal Biotech, Inc. Profile Avatar - Palmy Investing

Krystal Biotech, Inc.

Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical…
Biotechnology
US, Pittsburgh [HQ]
Strategy & Leadership

Qualitative Analysis

Business

Framework: SWOT 7's
End of KRYS's Analysis
CIK: 1711279 CUSIP: 501147102 ISIN: US5011471027 LEI: - UEI: -
Secondary Listings
KRYS has no secondary listings inside our databases.